Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
CD1C and hemophilia are reported together in 1 article.
Gene
CD1C
- HGNC
- HGNC:1636
1articles
1mentions
0variants with confirmed gene link
Most co-reported phenotypes (articles)
Phenotype
Hemophilia
122articles
122mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
1 records shown · first 60Effect of DNA methylation on inhibitor development in people with hemophilia A treated with FVIII concentrates.
PMID 40502981 | PMCID PMC12152321 | DOI 10.1016/j.rpth.2025.102858 · Research and practice in thrombosis and haemostasis · 2025 · 11 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | CD1C | “Association of CpG sites to a few genes involved in active immune response (JAK1, CD1C, PIGR, TOLLIP, BLNK, CD44, IL23R, IFNLR1, SOCS2, TLR1, etc.) was seen in inhibitor-positive patients, but it did not indicate specific pathways associated with inhibitor development.” | 0.98 | hgnc_dict_v1 |
| phenotype | hemophilia | “Effect of DNA methylation on inhibitor development in people with hemophilia A treated with FVIII concentrates.” | 0.98 | phenotype_alias_lexicon_v2 |
| gene | JAK1 | “Association of CpG sites to a few genes involved in active immune response (JAK1, CD1C, PIGR, TOLLIP, BLNK, CD44, IL23R, IFNLR1, SOCS2, TLR1, etc.) was seen in inhibitor-positive patients, but it did not indicate specific pathways associated with inhibitor development.” | 0.98 | hgnc_dict_v1 |
| gene | PIGR | “Association of CpG sites to a few genes involved in active immune response (JAK1, CD1C, PIGR, TOLLIP, BLNK, CD44, IL23R, IFNLR1, SOCS2, TLR1, etc.) was seen in inhibitor-positive patients, but it did not indicate specific pathways associated with inhibitor development.” | 0.98 | hgnc_dict_v1 |